Organon & Co



Ebitda Cambiamento Data
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Celltrion KRW 221.03B 206.2B 2025-03
Cspc Pharmaceutical CNY 2.21B 275.77M 2023-12
Dianthus Therapeutics USD -31838000 1.96M 2024-12
Divis Laboratories Ltd 9.72B 2.29B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Kangmei Pharma -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 16.72M 1.05M 2024-09
Laboratorios Farma EUR 137.9M 93.62M 2024-12
Malin Corporation EUR -1100000 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD 7.74B 625M 2025-03
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Organigram Holdings CAD -16179000 63.98M 2024-12
Organon & Co USD 408M 67M 2025-03
Pharma Mar EUR -1054000 8.01M 2025-03
Qiagen NV USD 170.75M 7.38M 2025-03
Sartorius EUR 263M 114.5M 2025-03
Sino Biopharmaceutical CNY 3.2B 955.21M 2024-12
Tilray USD -101000 2.32M 2024-11



Organon & Co - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2025.